Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin’s Lymphoma (NHL) [clinicaltrials:NCT00100737]
Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin’s Lymphoma (NHL) [clinicaltrials:NCT00100737]
Bio2RDF identifier
NCT00100737
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00100737
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... after previous chemotherapy.
brief title [clinicaltrials_vocabulary:brief-title]
Comparing Interleukin-2 (IL-2) ...... h Non-Hodgkin’s Lymphoma (NHL)
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-01-06T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
CD20+ follicular B-cell non-hodgkins lymphoma (grade I, II,III)
interleukin-2
non-hodgkins lymphoma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2006-02-02T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00100737
official title [clinicaltrials_vocabulary:official-title]
A Phase 2 Randomized, Open-Lab ...... ed After Previous Chemotherapy
org study id [clinicaltrials_vocabulary:org-study-id]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2006-02-01T00:00:00Z
identifier
clinicaltrials:NCT00100737
title
Comparing Interleukin-2 (IL-2) ...... h Non-Hodgkin’s Lymphoma (NHL)
@en
type
label
Comparing Interleukin-2 (IL-2) ...... ) [clinicaltrials:NCT00100737]
@en